FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Azacitidine Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Celgene Corporation (Revised 12/19/2023)

Company Contact Information:
1-888-423-5436

Presentation	Posting Date	Related Information
Vidaza, Injection, 100 mg (NDC 0781-3253-94)	12/19/2023
Vidaza, Injection, 100 mg, Powder, Lyoph (NDC 0781-9253-94)	12/19/2023
Vidaza, Injection, 100 mg (NDC 0781-9253-94)	08/03/2023	Discontinuation of the manufacture of the drug

Cipla Limited (Reverified 03/05/2024)

Company Contact Information:
844-247-5287

Presentation	Posting Date	Related Information
Injection, 100 mg (NDC 69097-805-40)	03/05/2024	This presentation has been discontinued.
Azacitidine, Injection, 100 mg (NDC 69097-805-40)	08/03/2023	Discontinuation of the manufacture of the drug